Magazine

The leading source for ASAM society and addiction medicine news.

Forum Held to Discuss Expanding Access to Buprenorphine

by Matt Vandover | Jun 20, 2014
Dr. Corey Waller and Sen. Levin

About the forum: On Wednesday, June 18, 2014, Senators Carl Levin (D-MI) and Orrin Hatch (R-UT) hosted a forum on opioid addiction and obstacles that have made it difficult for patients to have access to buprenorphine. ASAM member Dr. Corey Waller, ABAM Diplomate, spoke on behalf of ASAM about raising the 100-patient limit. According to DATA 2000 physicians who meet certain requirements can prescribe buprenorphine to a limited number of patients (30 total patients in the 1st year and 100 thereafter upon being approved for an expanded waiver). There was discussion at the Forum about raising the 100-patient limit, allowing nurse practitioners and physician assistants prescribe and understanding the reasons why waivered physicians are not prescribing.

ASAM’s take: ASAM is concerned that prescribing limits restrict patient access to treatment. ASAM recommends that the patient limits be lifted in a graduated, thoughtful approach that focuses on higher levels of training for non-addiction certified physicians who are interested in prescribing beyond the 100-patient limit.

What you can do:

Features

Education & Training

Forum Held to Discuss Expanding Access to Buprenorphine

by Matt Vandover | Jun 20, 2014
Dr. Corey Waller and Sen. Levin

About the forum: On Wednesday, June 18, 2014, Senators Carl Levin (D-MI) and Orrin Hatch (R-UT) hosted a forum on opioid addiction and obstacles that have made it difficult for patients to have access to buprenorphine. ASAM member Dr. Corey Waller, ABAM Diplomate, spoke on behalf of ASAM about raising the 100-patient limit. According to DATA 2000 physicians who meet certain requirements can prescribe buprenorphine to a limited number of patients (30 total patients in the 1st year and 100 thereafter upon being approved for an expanded waiver). There was discussion at the Forum about raising the 100-patient limit, allowing nurse practitioners and physician assistants prescribe and understanding the reasons why waivered physicians are not prescribing.

ASAM’s take: ASAM is concerned that prescribing limits restrict patient access to treatment. ASAM recommends that the patient limits be lifted in a graduated, thoughtful approach that focuses on higher levels of training for non-addiction certified physicians who are interested in prescribing beyond the 100-patient limit.

What you can do:

Government Affairs

Forum Held to Discuss Expanding Access to Buprenorphine

by Matt Vandover | Jun 20, 2014
Dr. Corey Waller and Sen. Levin

About the forum: On Wednesday, June 18, 2014, Senators Carl Levin (D-MI) and Orrin Hatch (R-UT) hosted a forum on opioid addiction and obstacles that have made it difficult for patients to have access to buprenorphine. ASAM member Dr. Corey Waller, ABAM Diplomate, spoke on behalf of ASAM about raising the 100-patient limit. According to DATA 2000 physicians who meet certain requirements can prescribe buprenorphine to a limited number of patients (30 total patients in the 1st year and 100 thereafter upon being approved for an expanded waiver). There was discussion at the Forum about raising the 100-patient limit, allowing nurse practitioners and physician assistants prescribe and understanding the reasons why waivered physicians are not prescribing.

ASAM’s take: ASAM is concerned that prescribing limits restrict patient access to treatment. ASAM recommends that the patient limits be lifted in a graduated, thoughtful approach that focuses on higher levels of training for non-addiction certified physicians who are interested in prescribing beyond the 100-patient limit.

What you can do:

OP-ED

Forum Held to Discuss Expanding Access to Buprenorphine

by Matt Vandover | Jun 20, 2014
Dr. Corey Waller and Sen. Levin

About the forum: On Wednesday, June 18, 2014, Senators Carl Levin (D-MI) and Orrin Hatch (R-UT) hosted a forum on opioid addiction and obstacles that have made it difficult for patients to have access to buprenorphine. ASAM member Dr. Corey Waller, ABAM Diplomate, spoke on behalf of ASAM about raising the 100-patient limit. According to DATA 2000 physicians who meet certain requirements can prescribe buprenorphine to a limited number of patients (30 total patients in the 1st year and 100 thereafter upon being approved for an expanded waiver). There was discussion at the Forum about raising the 100-patient limit, allowing nurse practitioners and physician assistants prescribe and understanding the reasons why waivered physicians are not prescribing.

ASAM’s take: ASAM is concerned that prescribing limits restrict patient access to treatment. ASAM recommends that the patient limits be lifted in a graduated, thoughtful approach that focuses on higher levels of training for non-addiction certified physicians who are interested in prescribing beyond the 100-patient limit.

What you can do:

Your ASAM

Photo of Alex Krawczyk-KeefeThe Importance of Donating: One Family’s Story

A donation to honor a son and help those facing the devastating disease of addiction.

ASAM Speaks on FDA Boxed Warnings

ASAM testified on the best approaches to communicating information about the fetal effects in product labeling for methadone and buprenorphine

Brain Stimulation as a Potential Treatment for Addiction

Brain stimulation has been in use for decades as a potential treatment for psychiatric disorders. However, its use in addiction is relatively new.

PCSS Graphic

Ask the PCSS Expert: Counseling Requirements in Addiction Treatment?

A physician wrote the PCSS mentor network seeking advice on what type of counseling (group/individual/ AA, NA/ therapist) are typically required as part of addiction treatment.